Sumitomo Mitsui Trust Group’s Ascendis Pharma A/S ASND Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,904	Closed	-$256K	–	1180
2021 Q4	$256K	Sell	1,904 -578	-23%	-$86K	﹤0.01%	1142
2021 Q3	$396K	Buy	2,482 +128	+5%	+$17.5K	﹤0.01%	1121
2021 Q2	$310K	Sell	2,354 -168	-7%	-$22.4K	﹤0.01%	1146
2021 Q1	$325K	Buy	2,522 +230	+10%	+$35K	﹤0.01%	1110
2020 Q4	$382K	Sell	2,292 -53	-2%	-$8.76K	﹤0.01%	1084
2020 Q3	$362K	Buy	+2,345	New	+$337K	﹤0.01%	1061

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group's ASND Position: Q1 2022 in Review

Sumitomo Mitsui Trust Group sold out of Ascendis Pharma A/S (ASND) in Q1 2022, closing a stake of 1,904 shares — an estimated $256K sold.

Sumitomo Mitsui Trust Group first reported a position in ASND in Q3 2020 and held it in 6 quarters. The position peaked at $396K in Q3 2021. 178 funds tracked by Wall St. Rank hold ASND as of Q1 2022.

Sumitomo Mitsui Trust Group reported no remaining Ascendis Pharma A/S position as of Q1 2022 after selling out during the quarter.
Sumitomo Mitsui Trust Group sold 1,904 Ascendis Pharma A/S shares in Q1 2022, an estimated $256K.
Sumitomo Mitsui Trust Group first reported a position in Ascendis Pharma A/S in Q3 2020 and held it in 6 quarters.
Sumitomo Mitsui Trust Group's Ascendis Pharma A/S position peaked at $396K in Q3 2021.
178 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2022.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2022, filed 27 Apr 2022.